Drugs / apantamide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05713578 | Mar 2023 → Feb 2026 overdue | — | Qilu Hospital of Shandong University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | apantamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05713578 ↗ |
| Route | Oral | “once a day, orally” NCT05713578 ↗ |